Oakbrook Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,800	Closed	-$1.32M	–	627
2019 Q3	$1.32M	Buy	+7,800	New	+$1.38M	0.09%	173
2019 Q1	–	Sell	-9,425	Closed	-$1.56M	–	645
2018 Q4	$1.56M	Sell	9,425 -7,675	-45%	-$1.33M	0.11%	145
2018 Q3	$3.3M	Sell	17,100 -275	-2%	-$49K	0.18%	90
2018 Q2	$2.95M	Sell	17,375 -645	-4%	-$100K	0.19%	87
2018 Q1	$2.94M	Buy	18,020 +1,625	+10%	+$265K	0.18%	89
2017 Q4	$2.46M	Sell	16,395 -4,380	-21%	-$649K	0.16%	99
2017 Q3	$3.16M	Buy	20,775 +1,050	+5%	+$158K	0.2%	89
2017 Q2	$2.54M	Buy	+19,725	New	+$2.37M	0.17%	110
2016 Q2	–	Sell	-24,220	Closed	-$1.93M	–	593
2016 Q1	$1.93M	Buy	24,220 +10,000	+70%	+$905K	0.12%	146
2015 Q4	$1.79M	Sell	14,220 -6,430	-31%	-$776K	0.11%	155
2015 Q3	$2.15M	Buy	20,650 +350	+2%	+$45K	0.14%	139
2015 Q2	$2.51M	Sell	20,300 -9,975	-33%	-$1.26M	0.15%	136
2015 Q1	$3.57M	Buy	30,275 +12,275	+68%	+$1.47M	0.19%	122
2014 Q4	$2.14M	Sell	18,000 -19,350	-52%	-$2.18M	0.12%	167
2014 Q3	$4.2M	Sell	37,350 -27,203	-42%	-$2.59M	0.23%	106
2014 Q2	$6.11M	Sell	64,553 -9,150	-12%	-$642K	0.18%	135
2014 Q1	$5.21M	Sell	73,703 -7,950	-10%	-$630K	0.16%	144
2013 Q4	$6.07M	Sell	81,653 -7,550	-8%	-$526K	0.17%	141
2013 Q3	$6.76M	Buy	89,203 +67,250	+306%	+$5.35M	0.2%	123
2013 Q2	$1.76M	Buy	+21,953	New	+$1.62M	0.05%	302